bioRxiv · 10.1101/2024.06.03.597122
Acoustic chip for rapid label-free early-stage detection of rare leukemic cells
Abstract
We present a promising approach for detecting as few as 1% of rare leukemia cells during the early stages of blood cancers. This study demonstrates a novel microfluidic chip utilizing a bulk piezoelectric ceramic device to manipulate cells with sound waves. By analyzing the movement patterns of normal mononuclear cells (MNCs) and abnormal THP-1 acute myeloid leukemia (AML) cells within an acoustic field, we observed distinct behaviors. Our findings suggest a label-free, non-targeted approach for sensitive detection of rare abnormal cells within a mixed population. This method, based on acoustophoresis principles, holds promise for analyzing biophysical properties of individual cells for early cancer diagnosis, potentially leading to earlier intervention and improved patient outcomes for leukemia. While this study focuses on microscopic analysis, we also discuss the potential for developing large-scale acoustophoresis-based methods for high-throughput rare cell detection using high-resolution nanofabrication techniques.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Matarese, B. F. E., Flewitt, A., Huntly, B. J. P.. 2024-06-04. Acoustic chip for rapid label-free early-stage detection of rare leukemic cells. https://doi.org/10.1101/2024.06.03.597122
Cite the original work for its findings. Save a collection to share your selection of sources.